Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-Cov-2 strains.

A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.

The new bivalent boosters against COVID-19 have failed to halt omicron infections. However, new technologies are being developed that pave a way forward.

An overactive immune response to infection can be deadly. Studying how one key player called tumor necrosis factor, or TNF, induces lethal immune responses could provide new treatment targets.

An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.

A new species of bacteria that doesn’t normally live in the gut may trigger an immune response so strong that it spreads to the joints.

Study indicates ailing neurons may instigate an inflammatory response from the brain’s microglia immune cells.

On World Rabies Day – which is also the anniversary of French microbiologist Louis Pasteur’s death – a virologist reflects on the achievements of this visionary scientist.

Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.

A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.